Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
27 October 1981Website:
http://www.baxter.comNext earnings report:
26 July 2024Last dividends:
31 May 2024Next dividends:
N/APrice
after hours | Mon, 01 Jul 2024 23:31:57 GMTAnalysts recommendations
Institutional Ownership
Included in screeners
BAX Latest News
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Baxter's (BAX) approval of the new expanded indication for Clinolipid is anticipated to address the varied nutritional requirements of patients, including preterm neonates and adults.
"Focus on one thing and excel at it." Companies often stray from this wise counsel, opting to expand into multiple areas.
Baxter International (BAX) reported quarterly earnings of $0.65 per share, surpassing the Zacks Consensus Estimate of $0.61 per share. This is an improvement from earnings of $0.59 per share in the same quarter last year.
While the revenue and EPS figures for Baxter (BAX) provide insight into its performance in the first quarter of March 2024, it may be beneficial to also evaluate how certain key metrics stack up against analyst expectations and the previous year's results.
In addition to Wall Street's expected financial performance for Baxter (BAX), take a look at projections for its important metrics to get a better insight into how the company performed in the first quarter of 2024.
Baxter introduces five new injectable products to enhance its focus on innovative products and broaden its pharmaceutical portfolio in key therapeutic areas.
In this article, we talk about three medical device companies - Cardinal Health (CAH), Baxter International (BAX), and Fresenius Medical Care (FMS) - all of which have shown consistent dividend growth over the past five years.
What type of business is Baxter International?
Baxter International Inc. through its subsidiaries develops and provides a wide portfolio of medical products. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. The company offers the following products and solutions: systems for dialysis therapy (peritoneal dialysis and hemodialysis), sterile intravenous solutions, infusion systems and devices, parenteral nutrition, inhalation anesthetics, and universal injectable pharmaceuticals. Baxter International also provides biological products and medical devices, surgical hemostats and sealants used in surgical procedures for hemostasis, tissue sealing, and prevention of adhesion.
What sector is Baxter International in?
Baxter International is in the Healthcare sector
What industry is Baxter International in?
Baxter International is in the Medical Instruments & Supplies industry
What country is Baxter International from?
Baxter International is headquartered in United States
When did Baxter International go public?
Baxter International initial public offering (IPO) was on 27 October 1981
What is Baxter International website?
https://www.baxter.com
Is Baxter International in the S&P 500?
Yes, Baxter International is included in the S&P 500 index
Is Baxter International in the NASDAQ 100?
No, Baxter International is not included in the NASDAQ 100 index
Is Baxter International in the Dow Jones?
No, Baxter International is not included in the Dow Jones index
When does Baxter International report earnings?
The next expected earnings date for Baxter International is 26 July 2024